Haemodynamic and transport barriers to the treatment of solid tumours.
about
Is inflammation a consequence of extracellular hyperosmolarity?Combined anti-angiogenic therapy targeting PDGF and VEGF receptors lowers the interstitial fluid pressure in a murine experimental carcinomaDCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia.Molecular regulation of tumor angiogenesis and perfusion via redox signaling.Use of preferentially replicating bacteria for the treatment of cancer.Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancersBenign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstructionMyths concerning the use of cationic liposomes in vivo.Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry.Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse.Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.Optimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated Vesicles.Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation.Tyrosine kinase inhibitors in pediatric malignancies.Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal modelPlasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivoDynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy.Reversible masking using low-molecular-weight neutral lipids to achieve optimal-targeted delivery.Effect of wall compliance and permeability on blood-flow rate in counter-current microvessels formed from anastomosis during tumor-induced angiogenesis.Higher dose and dose-rate in smaller tumors result in improved tumor control.Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule.Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.
P2860
Q21245655-BF0E0CE1-5A4D-4AD0-B302-AAB8BC69023DQ28472150-C0BBD280-C505-47C9-A8F6-7AE11CB4992AQ30388286-57EE2AED-34D1-48A8-8077-7D59BC8C26A3Q33572306-7C24D656-35FC-44E2-B2D0-A3A0C7F2F7EFQ33895307-4EF21D87-48A2-4AF8-A09C-0C672DC88B89Q34768326-C9452766-8BBD-4C27-AEEE-75506B41404DQ34943820-14EFEDEF-2E32-455F-BB98-BA52380064FFQ35116145-5BE0ECCD-C7CD-4466-ADB4-94717F1B2435Q35796256-9952E7EE-7576-43EA-AE20-5094756789F2Q35975895-C6BC6AE3-E2B2-4717-9BBD-9560884EC5FCQ36080718-0F576689-63F4-4D12-98C7-D972B2C5550BQ36080760-5A9B220E-2E37-4AFD-84A3-DAE1FF07B2E3Q36334067-050994E4-5402-45A8-A70B-A630B418B909Q36782265-0E1B15AB-1BAB-40A7-960E-383BA731F5FAQ36977823-C45F8F8D-7840-47B2-A44E-F9A237191D20Q37385797-9F62D910-62A3-4A2C-B15D-6F98D0DDFD4AQ40738194-CD7767B7-9B87-4516-889F-3FF03E2715D8Q41936147-AB2115DC-1475-4187-A46C-E563059BBEACQ42116177-FAC89D00-32C2-42CB-89E3-EFCA5B7D6910Q42177203-58C49033-6BA9-4AD1-A5F1-8117F2401BEFQ43100692-C32117F5-2A2C-4EC8-AAF9-BDC3158A3E8DQ44538713-02BB87AB-8CF5-4AC6-A29E-FE08E23C65BAQ47978622-C09FB954-E794-41B6-BDEB-88A387F611C0Q50575839-328BCF83-B46D-4609-8BFE-F13989C72140
P2860
Haemodynamic and transport barriers to the treatment of solid tumours.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Haemodynamic and transport barriers to the treatment of solid tumours.
@ast
Haemodynamic and transport barriers to the treatment of solid tumours.
@en
type
label
Haemodynamic and transport barriers to the treatment of solid tumours.
@ast
Haemodynamic and transport barriers to the treatment of solid tumours.
@en
prefLabel
Haemodynamic and transport barriers to the treatment of solid tumours.
@ast
Haemodynamic and transport barriers to the treatment of solid tumours.
@en
P2860
P1476
Haemodynamic and transport barriers to the treatment of solid tumours.
@en
P2093
P2860
P304
P356
10.1080/09553009114551621
P577
1991-07-01T00:00:00Z